MED-EL Corporation Launches Revolutionary Cochlear Implant in Canada

PULSARCI100 Reduces Need For Additional Surgery

Jun 01, 2005, 01:00 ET from MED-EL

    RESEARCH TRIANGLE PARK, N.C., June 1 /PRNewswire/ -- MED-EL Corporation, a
 North American implantable hearing technology firm, announced today that it
 has received approval to distribute a revolutionary cochlear implant system -
 the PULSARCI100 into the Canadian market. This new system is the first to
 incorporate the patented I100 technology, a highly durable and power-efficient
 electronics platform with wafer-thin layers of sophisticated electronics
 arranged on a single miniaturized chip.
     "The PULSARCI100 implant offers a number of potential advantages when
 compared to other available devices," says Dr. Lorne Parnes of the London
 Health Sciences Center in London, Ontario. "Its thinner and longer electrode
 design allows for a less traumatic and deeper insertion, which translates into
 more potential for some natural hearing preservation and more precise
 stimulation of lower, important speech frequencies."  Last month, Dr. Parnes
 became the first to implant a Pulsar device in Canada.
     One of Pulsar's most attractive and key features is that it is safe and
 compatible for use with magnetic resonance imaging (MRI) at field strengths of
 0.2, 1.0 and 1.5 Tesla. Other cochlear implant devices require a minor
 surgical procedure to remove some parts of the device before an MRI can be
     "We are always looking for ways to improve the understanding of speech in
 difficult listening environments and appreciation of music by our cochlear
 implant users," says Kim Jackson, Interim CEO of MED-EL Corporation.
 "Improving our patients' quality of life is our foremost concern.  We are
 proud to be serving the deaf community in Canada."
     Cochlear implants were developed in the 1970's to help severe to
 profoundly deaf individuals who gain little or no benefit from hearing aids.
 Patients wear a small speech processor behind the ear that picks up sound from
 the environment and transmits it to an internal component using specialized
 radio-frequency transmission.
     About MED-EL Corporation
     Since its founders developed one of the world's first cochlear implants in
 1975, MED-EL has set new standards in hearing implant technologies, developing
 and manufacturing technologically advanced hearing solutions for people with
 varying degrees of hearing loss. MED-EL hearing implant systems, currently
 used in 70 countries, combines the latest scientific advancements and
 pioneering engineering and manufacturing techniques for performance, safety
 and reliability. For more information, see or call (888)
 MED-EL-CI (633-3524).
      CONTACT:  Kelly Wahl